Status of work in September
AOTMiT begins work on the Ministry of Health’s orders in September:
- Kayfanda (odevixibatum) for the treatment of patients with Alagille syndrome
- Calquence (acalabrutinibum) for the treatment of patients with B-cell lymphomas
- Akantior (polihexanidum) for the treatment of Acanthamoeba keratitis in adults and children aged 12 years and older
The listed order is available on the AOTMiT Public Information Bulletin.